miR-25-3p promotes proliferation and inhibits autophagy of renal cells in polycystic kidney mice by regulating ATG14-Beclin 1

References

• Chou LF, Cheng YL, Hsieh CY, et al. Effect of trehalose supplementation on autophagy and cystogenesis in a mouse model of polycystic kidney disease. Nutrients. 2018;11:42.
   Web of Science ®Google Scholar
• Torres VE, Harris PC. Strategies targeting cAMP signaling in the treatment of polycystic kidney disease. J Am Soc Nephrol. 2014;25:18–32.
   PubMed Web of Science ®Google Scholar
• Aguiari G, Catizone L, Senno LD. Multidrug therapy for polycystic kidney disease: a review and perspective. Am J Nephrol. 2013;37:175–182.
   PubMed Web of Science ®Google Scholar
• Chang MY, Ong ACM. Targeting new cellular disease pathways in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant. 2017;32:2144–2144.
   PubMed Web of Science ®Google Scholar
• Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell. 2011;147:728–741.
   PubMed Web of Science ®Google Scholar
• Nazio F, Cecconi F. Autophagy up and down by outsmarting the incredible ULK. Autophagy. 2017;13:967–968.
   PubMed Web of Science ®Google Scholar
• Yu FS, Yu CS, Chen JC, et al. Tetrandrine induces apoptosis Via caspase-8, -9, and -3 and poly (ADP ribose) polymerase dependent pathways and autophagy through beclin-1/LC3-I, II signaling pathways in human oral cancer HSC-3 cells. Environ Toxicol. 2016;31:395–406.
   PubMed Web of Science ®Google Scholar
• Duan J, Du J, Jin R, et al. Iron oxide nanoparticles promote vascular endothelial cells survival from oxidative stress by enhancement of autophagy. Regen Biomater. 2019;6:221–229.
   PubMed Web of Science ®Google Scholar
• Amaravadi R, Kimmelman AC, White E. Recent insights into the function of autophagy in cancer. Genes Dev. 2016;30:1913–1930.
   PubMed Web of Science ®Google Scholar
• Ding Y, Choi ME. Autophagy in diabetic nephropathy. J Endocrinol. 2015;224:R15–30.
   PubMed Web of Science ®Google Scholar
• Sun L, Hu C, Zhang X. Histone deacetylase inhibitors reduce cysts by activating autophagy in polycystic kidney disease. Kidney Dis. 2019;5:163–172.
   Google Scholar
• Aguilar A. Polycystic kidney disease: autophagy boost to treat ADPKD? Nat Rev Nephrol. 2017;13:134–134.
   PubMed Web of Science ®Google Scholar
• Zhu P, Sieben CJ, Xu X, et al. Autophagy activators suppress cystogenesis in an autosomal dominant polycystic kidney disease model. Hum Mol Genet. 2017;26:158–172.
   PubMed Web of Science ®Google Scholar
• Wu T, Hu H, Zhang T, et al. miR-25 promotes cell proliferation, migration, and invasion of non-small-cell lung cancer by targeting the LATS2/YAP signaling pathway. Oxid Med Cell Longev. 2019;2019:9719723.
   PubMed Web of Science ®Google Scholar
• Duan Q, Si E. MicroRNA-25 aggravates Abeta1-42-induced hippocampal neuron injury in Alzheimer’s disease by downregulating KLF2 via the Nrf2 signaling pathway in a mouse model. 2019;120:15891–15905.
   Google Scholar
• Duan Q, Si E. MicroRNA-25 aggravates Aβ1-42-induced hippocampal neuron injury in Alzheimer’s disease by downregulating KLF2 via the Nrf2 signaling pathway in a mouse model. J Cell Biochem. 2019;120:15891–15905.
   PubMed Web of Science ®Google Scholar
• Li D, Wang T, Lai J, et al. Long non-coding RNA GATA6-AS inhibits gastric cancer cell proliferation by downregulating microRNA-25-3p. Oncol Lett. 2019;18:4639–4644.
   PubMed Web of Science ®Google Scholar
• Xu JY, Yang LL, Ma C, et al. MiR-25-3p attenuates the proliferation of tongue squamous cell carcinoma cell line Tca8113. Asian Pac J Trop Med. 2013;6:743–747.
   PubMed Web of Science ®Google Scholar
• Wang Z, Wang N, Liu P, et al. MicroRNA-25 regulates chemoresistance-associated autophagy in breast cancer cells, a process modulated by the natural autophagy inducer isoliquiritigenin. Oncotarget. 2014;5:7013–7026.
   PubMedGoogle Scholar
• Peng G, Yang C, Liu Y, et al. miR-25-3p promotes glioma cell proliferation and migration by targeting FBXW7 and DKK3. Exp Ther Med. 2019;18:769–778.
   PubMed Web of Science ®Google Scholar
• Mizushima N, Yoshimori T, Ohsumi Y. The role of Atg proteins in autophagosome formation. Annu Rev Cell Dev Biol. 2011;27:107–132.
   PubMed Web of Science ®Google Scholar
• Tan X, Thapa N, Liao Y, et al. PtdIns(4,5)P2 signaling regulates ATG14 and autophagy. Proc Natl Acad Sci U S A. 2016;113:10896–10901.
   PubMed Web of Science ®Google Scholar
• Yu C, Gorantla SP, Muller-Rudorf A, et al. Phosphorylation of Beclin-1 by BCR-ABL suppresses autophagy in chronic myeloid leukemia. Haematologica. 2019;105.
   Web of Science ®Google Scholar
• Sun L, Zhao M, Liu M, et al. Suppression of FoxO3a attenuates neurobehavioral deficits after traumatic brain injury through inhibiting neuronal autophagy. Behav Brain Res. 2018;337:271–279.
   PubMed Web of Science ®Google Scholar
• Liu H, Huan L, Yin J, et al. Role of microRNA-130a in myocardial hypoxia/reoxygenation injury. Exp Ther Med. 2017;13:759–765.
   PubMed Web of Science ®Google Scholar
• Shibazaki S, Yu Z, Nishio S, et al. Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1. Hum Mol Genet. 2008;17:1505–1516.
   PubMed Web of Science ®Google Scholar
• Duan ZY, Cai GY, Li JJ, et al. U6 can be used as a housekeeping gene for urinary sediment miRNA studies of IgA nephropathy. Sci Rep. 2018;8:10875–10875.
   PubMed Web of Science ®Google Scholar
• Hu H, Dong Z, Wang X, et al. Dehydrocorydaline inhibits cell proliferation, migration and invasion via suppressing MEK1/2-ERK1/2 cascade in melanoma. Onco Targets Ther. 2019;12:5163–5175.
   PubMed Web of Science ®Google Scholar
• Su Y, Wen Z, Shen Q, et al. Long non-coding RNA LOC100507600 functions as a competitive endogenous RNA to regulate BMI1 expression by sponging miR128-1-3p in Hirschsprung’s disease. Cell Cycle (Georgetown, Tex.). 2018;17:459–467.
   PubMed Web of Science ®Google Scholar
• Lee KY, Fu H, Aladjem MI, et al. ATAD5 regulates the lifespan of DNA replication factories by modulating PCNA level on the chromatin. J Cell Biol. 2013;200:31–44.
   PubMed Web of Science ®Google Scholar
• Yheskel M, Patel V. Therapeutic microRNAs in polycystic kidney disease. Curr Opin Nephrol Hypertens. 2017;26:282–289.
   PubMed Web of Science ®Google Scholar
• Hajarnis S, Lakhia R, Yheskel M, et al. microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism. Nat Commun. 2017;8:14395–14395.
   PubMed Web of Science ®Google Scholar
• de Stephanis L, Mangolini A, Servello M, et al. MicroRNA501-5p induces p53 proteasome degradation through the activation of the mTOR/MDM2 pathway in ADPKD cells. J Cell Physiol. 2018;233:6911–6924.
   PubMed Web of Science ®Google Scholar
• Lakhia R, Hajarnis S, Williams D, et al. MicroRNA-21 aggravates cyst growth in a model of polycystic kidney disease. J Am Soc Nephrol. 2016;27:2319–2330.
   PubMed Web of Science ®Google Scholar
• Yu A, Zhang T, Zhong W, et al. miRNA-144 induces microglial autophagy and inflammation following intracerebral hemorrhage. Immunol Lett. 2017;182:18–23.
   PubMed Web of Science ®Google Scholar
• Wu W, Shan Z, Wang R, et al. Overexpression of miR-223 inhibits foam cell formation by inducing autophagy in vascular smooth muscle cells. Am J Transl Res. 2019;11:4326–4336.
   PubMed Web of Science ®Google Scholar
• Xu CX, Xu L, Peng FZ, et al. MiR-647 promotes proliferation and migration of ox-LDL-treated vascular smooth muscle cells through regulating PTEN/PI3K/AKT pathway. Eur Rev Med Pharmacol Sci. 2019;23:7110–7119.
   PubMedGoogle Scholar
• Fan L, Wang Y, Huo W, et al. MicroRNA301a3p overexpression promotes cell invasion and proliferation by targeting runtrelated transcription factor 3 in prostate cancer. Mol Med Rep. 2019;20:3755–3763.
   PubMed Web of Science ®Google Scholar
• Sun L, Zhu J, Wu M, et al. Inhibition of MiR-199a-5p reduced cell proliferation in autosomal dominant polycystic kidney disease through targeting CDKN1C. Med Sci Monit. 2015;21:195–200.
   PubMed Web of Science ®Google Scholar
• Patel V, Williams D, Hajarnis S, et al. miR-17 ∼ 92 miRNA cluster promotes kidney cyst growth in polycystic kidney disease. Proc Natl Acad Sci U S A. 2013;110:10765–10770.
   PubMed Web of Science ®Google Scholar
• Feng L, Xia B, Tian BF, et al. MiR-152 influences osteoporosis through regulation of osteoblast differentiation by targeting RICTOR. Pharm Biol. 2019;57:586–594.
   PubMed Web of Science ®Google Scholar
• Zeng Y, Gao T, Huang W, et al. The microRNA-455-3p mediates GATA3 tumor suppression in mammary epithelial cells by inhibiting TGF-beta signaling. J Biol Chem. 2019;294:15808–15825.
   PubMed Web of Science ®Google Scholar
• Song J, Li Y. miR-25-3p reverses epithelial-mesenchymal transition via targeting Sema4C in cisplatin-resistance cervical cancer cells. Cancer Sci. 2017;108:23–31.
   PubMed Web of Science ®Google Scholar
• Wan W, Wan W, Long Y, et al. MiR-25-3p promotes malignant phenotypes of retinoblastoma by regulating PTEN/Akt pathway. Biomed Pharmacother. 2019;118:109111.
   PubMed Web of Science ®Google Scholar
• Sun L, Zhao M, Zhang J, et al. MiR-29b downregulation induces phenotypic modulation of vascular smooth muscle cells: implication for intracranial aneurysm formation and progression to rupture. Cell Physiol Biochem. 2017;41:510–518.
   PubMedGoogle Scholar
• He J, Yu JJ, Xu Q, et al. Downregulation of ATG14 by EGR1-MIR152 sensitizes ovarian cancer cells to cisplatin-induced apoptosis by inhibiting cyto-protective autophagy. Autophagy. 2015;11:373–384.
   PubMed Web of Science ®Google Scholar